Abstract
Resistance to vancomycin and high level aminoglycosides are common among Enterococcus spp. and are being increasingly reported from different parts of the world. These resistance phenomena in enterococci have limited the therapeutic options to treat the infections caused by them. The objective of our study was to determine the antimicrobial resistance patterns of Enterococcus spp. (n=60) isolated over a year from clinical specimens received from patients visiting Nepal Medical College Teaching Hospital, Kathmandu, Nepal. All enterococci were subjected to antimicrobial susceptibility testing, high level gentamicin resistance testing by disc diffusion method and minimum inhibitory concentration of vancomycin by agar dilution method. Prevalence of high level gentamicin resistance among enterococci was 55%. None of the isolates were resistant to vancomycin by both disc diffusion and agar dilution method. However 8.3% of them were intermediate to vancomycin. All of these vancomycin intermediate isolates were from samples from hospital admitted patients and resistant to ampicillin, ciprofloxacin, erythromycin and high level gentamicin. Present findings were suggestive of possible emergence of vancomycin resistant enterococci in the hospital if immediate and adequate control measures are not implemented.
Highlights
Enterococcus spp., the natural inhabitants of the intestinal tract of humans and animals have received attention in recent times due to their increasing role in nosocomial infections.[1]
A descriptive cross sectional study was conducted over a year (July, 2017- June 2018) in the microbiology laboratory of Nepal Medical College Teaching Hospital (NMCTH), Kathmandu, Nepal
Enterococcus spp were identified by studying colony characters, gram staining, catalase test and biochemical tests according to the standard microbiological techniques.[14]
Summary
Enterococcus spp., the natural inhabitants of the intestinal tract of humans and animals have received attention in recent times due to their increasing role in nosocomial infections.[1]. Vancomycin resistance among Enterococcus spp. has been reported all over the world and is in rising trend.[8,9,10]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
